Skip to main content
. 2023 Jan 12;102(3):651–661. doi: 10.1007/s00277-023-05084-x

Fig. 1.

Fig. 1

Flow chart of patient selection strategy. Flu/Bu2, fludarabine with reduced-intensity busulfan; Flu/Bu4, fludarabine with myeloablative busulfan; HCT, hematopoietic cell transplantation; NHL, non-Hodgkin lymphoma; PS matching, propensity score matching; TBI, total body irradiation; TRUMP 2, Transplant Registry Unified Management Program 2